Insight Genetics
Oncocyte to Acquire Insight Genetics for $12M
Insight's portfolio includes a gene expression-based immuno-oncology assay for therapy response prediction.
Insight's portfolio includes a gene expression-based immuno-oncology assay for therapy response prediction.